Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests

Alzheimer’s disease (AD) is a critical health issue worldwide that has a negative impact on patients’ quality of life, as well as on caregivers, society, and the environment. Positron emission tomography (PET)/computed tomography (CT) and neuropsychological scales can be used to identify AD and mild...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qing, Du, Xinxin, Chen, Wenhong, Zhang, Ting, Xu, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363609/
https://www.ncbi.nlm.nih.gov/pubmed/37492405
http://dx.doi.org/10.3389/fnins.2023.1216215
_version_ 1785076666902511616
author Zhao, Qing
Du, Xinxin
Chen, Wenhong
Zhang, Ting
Xu, Zhuo
author_facet Zhao, Qing
Du, Xinxin
Chen, Wenhong
Zhang, Ting
Xu, Zhuo
author_sort Zhao, Qing
collection PubMed
description Alzheimer’s disease (AD) is a critical health issue worldwide that has a negative impact on patients’ quality of life, as well as on caregivers, society, and the environment. Positron emission tomography (PET)/computed tomography (CT) and neuropsychological scales can be used to identify AD and mild cognitive impairment (MCI) early, provide a differential diagnosis, and offer early therapies to impede the course of the illness. However, there are few reports of large-scale (11)C-PIB-PET/CT investigations that focus on the pathology of AD and MCI. Therefore, further research is needed to determine how neuropsychological test scales and PET/CT measurements of disease progression interact.
format Online
Article
Text
id pubmed-10363609
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103636092023-07-25 Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests Zhao, Qing Du, Xinxin Chen, Wenhong Zhang, Ting Xu, Zhuo Front Neurosci Neuroscience Alzheimer’s disease (AD) is a critical health issue worldwide that has a negative impact on patients’ quality of life, as well as on caregivers, society, and the environment. Positron emission tomography (PET)/computed tomography (CT) and neuropsychological scales can be used to identify AD and mild cognitive impairment (MCI) early, provide a differential diagnosis, and offer early therapies to impede the course of the illness. However, there are few reports of large-scale (11)C-PIB-PET/CT investigations that focus on the pathology of AD and MCI. Therefore, further research is needed to determine how neuropsychological test scales and PET/CT measurements of disease progression interact. Frontiers Media S.A. 2023-07-10 /pmc/articles/PMC10363609/ /pubmed/37492405 http://dx.doi.org/10.3389/fnins.2023.1216215 Text en Copyright © 2023 Zhao, Du, Chen, Zhang and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zhao, Qing
Du, Xinxin
Chen, Wenhong
Zhang, Ting
Xu, Zhuo
Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
title Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
title_full Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
title_fullStr Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
title_full_unstemmed Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
title_short Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
title_sort advances in diagnosing mild cognitive impairment and alzheimer’s disease using (11)c-pib- pet/ct and common neuropsychological tests
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363609/
https://www.ncbi.nlm.nih.gov/pubmed/37492405
http://dx.doi.org/10.3389/fnins.2023.1216215
work_keys_str_mv AT zhaoqing advancesindiagnosingmildcognitiveimpairmentandalzheimersdiseaseusing11cpibpetctandcommonneuropsychologicaltests
AT duxinxin advancesindiagnosingmildcognitiveimpairmentandalzheimersdiseaseusing11cpibpetctandcommonneuropsychologicaltests
AT chenwenhong advancesindiagnosingmildcognitiveimpairmentandalzheimersdiseaseusing11cpibpetctandcommonneuropsychologicaltests
AT zhangting advancesindiagnosingmildcognitiveimpairmentandalzheimersdiseaseusing11cpibpetctandcommonneuropsychologicaltests
AT xuzhuo advancesindiagnosingmildcognitiveimpairmentandalzheimersdiseaseusing11cpibpetctandcommonneuropsychologicaltests

Ejemplares similares